Nuveen
QNRX icon

Nuveen’s Quoin Pharmaceuticals QNRX Stock Holding History

Nuveen’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.13K Buy
+437
New +$2.35K ﹤0.01% 4840

Other funds holding QNRX

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Nuveen's QNRX Position: Q3 2026 in Review

Nuveen opened a new position in Quoin Pharmaceuticals (QNRX) in Q3 2026: 437 shares worth $2.13K. The stake represents ﹤0.01% of the portfolio and ranks #4840 among its holdings.

6 funds tracked by Wall St. Rank hold QNRX as of Q3 2026.

  • Nuveen held 437 shares of Quoin Pharmaceuticals worth $2.13K as of Q3 2026.
  • Quoin Pharmaceuticals was a new Nuveen position in Q3 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4840 holding.
  • 6 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.